Summit FeaturedFree
Global Summit on Immunotherapy & Cancer Biology
Registration
Registration for this event is managed by biosymposia.com. Click below to register on their official website.
Register on biosymposia.com WebsiteAbout This Event
An intensive two-day summit focused on the latest breakthroughs in cancer immunotherapy, tumor microenvironment research, and CAR-T cell therapies. Leading oncologists and immunologists will present phase III trial results, discuss combination therapy strategies, and explore the emerging role of the gut microbiome in treatment response. Includes a dedicated poster session and networking dinner.
Speakers
Program & Schedule
Day 1: Day 1 — CAR-T & Checkpoint Inhibitors
July 15, 2026
08:30–09:30
Opening Keynote: CAR-T 2.0keynote
Next-generation CAR-T constructs with improved persistence and safety.
09:45–11:00
Session: PD-1/PD-L1 Resistance Mechanisms
Understanding and overcoming checkpoint inhibitor resistance.
11:00–12:30
Lunch & Networkingbreak
12:30–14:00
Session: Bispecific Antibodies
Clinical data on bispecific T-cell engagers in hematologic malignancies.
14:00–16:00
Poster Sessionnetworking
Day 2: Day 2 — Tumor Microenvironment & Combination Therapy
July 16, 2026
08:30–09:30
Keynote: The Tumor Microenvironmentkeynote
Immunosuppressive mechanisms and strategies to overcome them.
09:45–11:00
Session: Combination Immunotherapy
Synergistic combinations of checkpoint inhibitors and targeted therapies.
11:00–12:00
Lunchbreak
12:00–13:30
Panel: Regulatory Pathways for Cell Therapiespanel
FDA and EMA perspectives on accelerated approval for novel immunotherapies.
13:30–14:30
Awards & Closingother
Venue & Location
Hyatt Regency Chicago, 151 E Wacker Dr, Chicago, IL 60601, Chicago, United States
Event Details
TypeSummit
FormatIn-Person
Capacity600
TimezoneAmerica/Chicago
AdmissionFree